Vident Investment Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-53,106	Closed	-$18.7M	–	1051
2023 Q2	$18.7M	Sell	53,106 -4,471	-8%	-$1.51M	0.64%	21
2023 Q1	$18.1M	Buy	57,577 +4,325	+8%	+$1.3M	0.59%	21
2022 Q4	$15.4M	Buy	53,252 +21,209	+66%	+$6.46M	0.58%	29
2022 Q3	$8.97M	Sell	32,043 -4,234	-12%	-$1.22M	0.29%	79
2022 Q2	$10.2M	Sell	36,277 -5,177	-12%	-$1.39M	0.31%	71
2022 Q1	$10.8M	Buy	41,454 +11,330	+38%	+$2.69M	0.28%	75
2021 Q4	$6.62M	Buy	30,124 +9,645	+47%	+$1.88M	0.17%	133
2021 Q3	$3.71M	Buy	20,479 +17,423	+570%	+$3.4M	0.11%	182
2021 Q2	$616K	Sell	3,056 -700	-19%	-$146K	0.02%	785
2021 Q1	$808K	Buy	3,756 +1,552	+70%	+$341K	0.03%	674
2020 Q4	$521K	Buy	2,204 +173	+9%	+$39.7K	0.02%	701
2020 Q3	$553K	Sell	2,031 -1,191	-37%	-$329K	0.03%	639
2020 Q2	$935K	Buy	+3,222	New	+$874K	0.05%	500
2018 Q2	–	Sell	-1,380	Closed	-$219K	–	976
2018 Q1	$219K	Buy	+1,380	New	+$225K	0.01%	842
2015 Q3	–	Sell	-50	Closed	-$6K	–	1157
2015 Q2	$6K	Buy	+50	New	+$6.3K	﹤0.01%	1003